Published 14:48 IST, November 20th 2020

Haryana Health Minister Anil Vij gets first dose in Covaxin vaccine's phase 3 trial

Haryana Health Minister Anil Vij on Friday was administered the first trial dose of Bharat Biotech's COVID-19 vaccine Covaxin at Civil Hospital at Ambala Cantt

Reported by: Gargi Rohatgi
Follow: Google News Icon
  • share
null | Image: self
Advertisement

In a big development in fight against Coronavirus pandemic, Haryana Health Minister Anil Vij on Friday was ministered first trial dose of Bharat Biotech's COVID-19 vaccine Covaxin at Civil Hospital in Ambala Cantt. Vij is first trial participant for Phase 3 trial which began in state on Friday. 67-year old senior BJP leer was given trial dose under expert supervision of a team of doctors from PGI Rohtak and Health Department. 

Taking to Twitter, Haryana Health Minister on Thursday anunced that he has volunteered to take trial dose of Covaxin. He furr informed that he will be ministered trial dose of indigeusly developed COVID-19 vaccine on Friday at around 11 am. 

Advertisement

RE | After Haryana & MP's Plans, Uttar Presh To Bring Law Against 'Love Jih'; Proposal Sent

Anil Vij urges people to participate in Covaxin trials 

While responding to questions about him volunteering for third phase of a vaccine trial, Vij said, "I appeal people to t hesitate from volunteering for vaccine trial. More and more people should come forward."

Urging people to participate in final phase trials, BJP leer informed that 25,800 people will be ministered with trial dose. Vij said, 'I, myself have stepped forward to take first dose of vaccine. I am t afraid of volunteering. In fact, I want more people to come forward so that trials can be completed as soon as possible and vaccine can be me available in market soon.'

Advertisement

RE | Phase 3 Trial Of Covaxin To Begin In Haryana On v 20, Health Minister Anil Vij Offers To Be First Volunteer

Bharat Biotech's Covaxin 

Covaxin is a COVID-19 vaccine that is being developed indigeusly by Bharat Biotech in collaboration with Indian Council of Medical Research (ICMR). early two trials of this vaccine were successfully completed. Bharat Biotech on Monday anunced that Phase 3 trial of Covaxin would involve 26,000 volunteers across 25 centres in India. company earlier h anunced that volunteers who wish to participate in trials should be ults over 18 years of .

Advertisement

RE | Haryana Health Minister Anil Vij To Get Covaxin Dose On Friday, Vaccine In Phase III Trial

India's COVID-19 statistics 

As world continues to grapple with COVID-19 pandemic, India so far has recorded over 9.05 lakh positive cases, out of which 83,35,109 have successfully recovered while 1,30,993 have died. As per latest updates from MoHFW, in past 24 hours, 38,617 new cases, 474 deaths and 44,739 fresh recoveries have been reported. Currently, total number of active Coronavirus cases in country is 4,46,805. 

Advertisement

Indian Council of Medical Research (ICMR) on Friday informed that until vember 19, 12,95,91,786 samples have been tested for Coronavirus. It furr informed that on vember 19, 10,83,397 samples were tested. 

RE | Haryana Forms Panel To Draft Law Against 'Love Jih'; HM, DGP Attend High-level Meeting

Advertisement

14:48 IST, November 20th 2020